Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs

Diabetes mellitus is an important risk factor for a first cardiovascular event and for worse outcomes after a cardiovascular event has occurred. This situation might be caused, at least in part, by the prothrombotic status observed in patients with diabetes. Therefore, contemporary antithrombotic st...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nature reviews cardiology 2019-02, Vol.16 (2), p.113-130
Hauptverfasser:	Patti, Giuseppe, Cavallari, Ilaria, Andreotti, Felicita, Calabrò, Paolo, Cirillo, Plinio, Denas, Gentian, Galli, Mattia, Golia, Enrica, Maddaloni, Ernesto, Marcucci, Rossella, Parato, Vito Maurizio, Pengo, Vittorio, Prisco, Domenico, Ricottini, Elisabetta, Renda, Giulia, Santilli, Francesca, Simeone, Paola, De Caterina, Raffaele
Format:	Artikel
Sprache:	eng
Schlagworte:	692/4019/592/75/593/567 692/699/2743/137/1418 692/699/2743/137/773 692/700/459/1748 692/700/565/1436 Aggregation Atherosclerotic plaque Blood Coagulation - drug effects Blood Coagulation - physiology Blood platelets Cardiac Imaging Cardiac Surgery Cardiology Cardiovascular disease Cardiovascular diseases Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Complications and side effects Consensus Statement Development and progression Diabetes Diabetes Mellitus - blood Diabetes Mellitus - drug therapy Diabetes Mellitus - epidemiology Disease prevention Dosage and administration Drug therapy Fibrinolytic Agents - pharmacology Health aspects Health risk assessment Humans Hypoglycemic agents Hypoglycemic Agents - pharmacology Medicine Medicine & Public Health Practice Guidelines as Topic Prevention Risk Factors Secondary Prevention - methods Secondary Prevention - trends Thrombolytic drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!